Dachaigh › Hypertension Sùla › Texas
Sgrùdaidhean clionaigeach Hypertension Sùla ann an Texas
Tha 8 sgrùdaidhean airson Hypertension Sùla a’ lorg phàirtichean aig làraichean ann an Texas.
Bailtean ann an Texas
Teacsa sgrùdaidh oifigeil (Beurla)
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07816692A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- Houston Eye Associates, Houston
- R and R eye research, San Antonio
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT04967989Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
A’ fastadhÌre 3
Aoisean 22 agus nas sine · Gach gnè · Air ùrachadh 20 Dàmh 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
A’ fastadhÌre 3
Aoisean 22 agus nas sine · Gach gnè · Air ùrachadh 20 Dàmh 2025 · NCT07218783Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Keystone Research, Austin
- Houston Eye Associates, North Loop, Houston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2022 · NCT05401357Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.